面部原发基底细胞癌的临床特征及手术治疗

韦明壮; 罗绮宁; 黄嘉韵; 颜文杰; 李湘

doi:10.13201/j.issn.1001-1781.2018.04.008

面部原发基底细胞癌的临床特征及手术治疗

- 1. 广东省中西医结合医院耳鼻咽喉科(广东佛山, 528200);
- 2. 广东省中西医结合医院病理科

详细信息

通讯作者: 韦明壮,E-mail:fsweimz@163.com

中图分类号: R739.81

收稿日期: 2017-09-18

The clinical features and surgical treatment of facial basal cell carcinoma

- 1. Department of Otolaryngology, Guangdong Province Hospital of Integrated Traditional Chinese and Western Medicine, Foshan, 528200, China;
- 2. Department of Pathology, Guangdong Province Hospital of Integrated Traditional Chinese and Western Medicine

More Information

Corresponding author: WEI Mingzhuang, E-mail: fsweimz@163.com

Received Date: 18 September 2017

摘要

摘要: 目的：探讨面部五官原发基底细胞癌（BCC）的临床特征及合理的手术治疗方案。方法：总结分析37例面部五官部位原发BCC的临床特征。手术切除原发病灶，术中冷冻病检，保证切缘干净；选择适合的皮瓣修复缺损。结果：术后随访12~36个月。37例中2例侧切缘见癌细胞残留，于术后4~6个月局部复发，局部复发率5.41%（2/37），治愈率94.59%（35/37）。切除后缺损区选用合适皮瓣修复，4例出现边缘部分坏死，经换药处理后愈合；其余全部皮瓣成活，外观效果满意。结论：面部五官原发BCC临床特征多种多样。首次彻底切除原发灶、保证切缘干净是治疗成功的关键；选择适合的方法修复缺损，可取得满意疗效。
- 癌,基底细胞 /
- 面部 /
- 外科手术
Abstract: Objective: To investigate the clinical features and reasonable surgical treatment of facial basal cell carcinoma (BCC).Method: The clinical features of primary facial BCC from 37 patients were analyzed.All patients were cured by standard surgical excision with intraoperative frozen section examination and ensuring margins negative,the defects were reconstructed by using adaptive flaps after resection.Result: The patients were followed up for 12 to 36 months after operation.Two cases of 37(2/37,5.41%) with unclear margin developed local recurrence during 4-6 months after resection,the cure rate was 94.59% (35/37). Except 4 cases were suffered with distal skin flap necrosis,the others were well developed.Conclusion: The clinical feature of primary facial basal cell carcinoma was various. The complete resection of primary nidus with clear margin is the key to a successful treatment of facial basal cell carcinoma, and satisfactory therapeutic effects can be obtained after repairing defects by using adaptive flaps after resection.
- carcinoma, basal cell /
- face /
- surgical procedures, operative

HTML全文

参考文献(22)

[1]	彭玉成, 岳波, 范静平, 面颈部基底细胞癌48例临床分析[J].临床耳鼻咽喉科杂志, 2008, 22(12):567-568.
[2]	LANOUE J, GOLDENBERG G.Basal Cell Carcinoma:A Comprehensive Review of Existing and Emerging Nonsurgical Therapies[J].J Clin Aesthet Dermatol, 2016, 9:26-36.
[3]	SINGAL A, DAULATABAD D, PANDHI D, et al.Facial Basal Cell Carcinoma Treated with Topical 5%Imiquimod Cream with DermoscopicEvaluation[J].J Cutan Aesthet Surg, 2016, 9:122-125.
[4]	CHRISTENSON L J, BORROWMAN T A, VACHON C M, et al.Incidence of basal cell and squamous cell carcinomas in a population younger than 40years[J].JAMA, 2005, 294:681-690.
[5]	WU T P, STEIN J A.Nonmelanoma skin cancer in young women[J].J Drugs Dermatol, 2013, 12:568-572.
[6]	SCRIVENER Y, GROSSHANS E, CRIBIER B.Variations of basal cell carcinomas according to gender, age, location and histopathological subtype[J].Br J Dermatol, 2002, 147:41-47.
[7]	MARZUKA A G, BOOK S E.Basal cell carcinoma:pathogenesis, epidemiology, clinical features, diagnosis, histopathology, and management[J].Yale J Biol Med, 2015, 88:167-179.
[8]	RUBIN A I, CHEN E H, RATNER D.Basal-cell carcinoma[J].N Engl J Med, 2005, 353:2262-2269.
[9]	NEWLANDS C, CURRIE R, MEMON A, et al.Non-melanoma skin cancer:United Kingdom National Multidisciplinary Guidelines[J].J Laryngol Otol, 2016, 130:S125-S132.
[10]	TELFER N R, COLVER G B, MORTON C A, et al.Guidelines for the management of basal cell carcinoma[J].Br J Dermatol, 2008, 159:35-48.
[11]	CHUNG S.Basal cell carcinoma[J].Arch Plast Surg, 2012, 39:166-170.
[12]	VOICU C, MIHAI M, LUPU M, et al.Pigmented Paraaxillary Located "Complex" Basal Cell Carcinoma Imitating clinically irritatedMelanocytic Lesion-Succesfull Surgical Approach in Bulgarian Patient[J].Open Access Maced J Med Sci, 2017, 5:497-500.
[13]	DOURMISHEV L A, RUSINOVA D, BOTEV I.Clinical variants, stages, and management of basal cell carcinoma[J].Indian Dermatol Online J, 2013, 4:12-17.
[14]	CHREN M M, LINOS E, TORRES J S, et al.Tumor recurrence 5years after treatment of cutaneous basal cell carcinoma and squamous cell carcinoma[J].J Invest Dermatol, 2013, 133:1188-1196.
[15]	SILVERMAN M K, KOPF A W, BART R S, et al.Recurrence rates of treated basal cell carcinomas.Part3:Surgical excision[J].J Dermatol Surg Oncol, 1992, 18:471-476.
[16]	BENATAR M, DUMAS P, CARDIO-LECCIA N, et al.Interest and reliability of frozen section biopsy in the treatment of skin tumors[J].Ann Chir Plast Esthet, 2012, 57:125-131.
[17]	FLAVIO B L, CAMILA F, GILBERTO P C.Surgical treatment of basal cell carcinoma:an algorithm based on the literature[J].An Bras Dermatol, 2015, 90:377-383.
[18]	VENTURINI M, GUALDI G, ZANCA A, et al.A new approach for presurgical margin assessment by reflectance confocal microscopy of basal cell carcinoma[J].Br J Dermatol, 2016, 174:380-385.
[19]	ITO T, INATOMI Y, NAGAE K, et al.Narrowmargin excision is a safe, reliable treatment for welldefined, primary pigmented basal cell carcinoma:an analysis of 288lesions in Japan[J].J Eur Acad Dermatol Venereol, 2015, 29:1828-1831.
[20]	FLAVIO B L, CAMILA F, GILBERTO P C.Analysis of effectiveness of a surgical treatment algorithm for basal cell carcinoma[J].An Bras Dermatol, 2016, 91:726-731.
[21]	LUZ F B, FERRON C, CARDOSO G P.Surgical treatment of basal cell carcinoma:an algorithm based on literature[J].An Bras Dermatol, 2015, 90:377-383.
[22]	GULLETH Y, GOLDBERG N, SILVERMAN R P, et al.What is the best surgical margin for a Basal cell carcinoma:a meta-analysis of the literature[J].Plast Reconstr Surg, 2010, 126:1222-1231.